(4-Methoxyphenyl)boronic acid → 4-[1-(4-Methoxy-phenyl)-1H-imidazol-4-yl]-3-phenyl-5-trifluoromethyl-isoxazole
Reaction equation
[NH:1]1[CH:5]=[C:4]([C:6]2[C:7]([C:15]3[CH:20]=[CH:19][CH:18]=[CH:17][CH:16]=3)=[N:8][O:9][C:10]=2[C:11]([F:14])([F:13])[F:12])[N:3]=[CH:2]1.[CH3:21][O:22][C:23]1[CH:28]=[CH:27][C:26](B(O)O)=[CH:25][CH:24]=1>>[CH3:21][O:22][C:23]1[CH:28]=[CH:27][C:26]([N:1]2[CH:5]=[C:4]([C:6]3[C:7]([C:15]4[CH:16]=[CH:17][CH:18]=[CH:19][CH:20]=4)=[N:8][O:9][C:10]=3[C:11]([F:14])([F:12])[F:13])[N:3]=[CH:2]2)=[CH:25][CH:24]=1Participants
3
Procedure
As described for Example 1j, 4-(1H-imidazol-4-yl)-3-phenyl-5-trifluoromethyl-isoxazole (100 mg, 0.36 mmol) was converted, using 4-methoxyphenylboronic acid instead of phenylboronic acid, to the title compound (90 mg, 65%) which was obtained as a white solid. MS (ESI): m/e=386.1 [M+H]+.
Sources & evidence
- ORD record
- ord-3fc0984277f2402489ea2f21d7cb32d9
- Source dataset
- uspto-grants-2010_12
- Patent number
- US07851469B2
Reaction notes
Loading…